COVID-19 Vaccines In Different Countries - Pfizer

Russia plans to use its own COVID-19 vaccine, Sputnik V, but it will combine it with the vaccine developed by AstraZeneca and Oxford to improve immunity protection. Brazil’s Pfizer COVID-19 vaccine order could arrive as early as December 2020 or January 2021.

Also, check out our research on;

Russia

There is no current indication that Russia intends to administer or order the COVID-19 vaccine developed by Pfizer. Instead, the country is depending on its own vaccine being developed by the Gamaleya Research Institute of Epidemiology & Microbiology (Moscow), called Sputnik V, which it claims will provide protection from the virus for two years.
In December 2020, Russia’s President, Vladimir Putin, ordered are large-scale vaccination for the country after touting Sputnik V for the past few months. The vaccine remains in phase three clinical trials, and its developers claim that it has an efficacy of more than 95%, though experts are skeptical of this. Mikhail Murashko, Russia’s health minister, also claimed that over 100,000 citizens have received a Sputnik V COVID-19 vaccination.
Nevertheless, the Russian Investment Fund is planning to evaluate a combination of Sputnik V with the AstraZeneca-Oxford vaccine by the conclusion of 2020. This particular move is being conducted in an effort to bolster immunity protection for those that may be given injections.

Brazil

On December 8, 2020, the Brazilian government signed on to a letter of intent with Pfizer to receive over 70 million doses of the COVID-19 vaccine. It is reported that these doses could arrive in Brazil sometime in January 2020, according to Eduardo Pazuello, Brazil’s Minister of Health.
However, a report from Xinhua published on December 9, 2020, states that the Brazilian government recently revealed that the country may begin administering the COVID-19 vaccines from Pfizer to its citizens as early as December 2020 or January 2021, depending on its date of arrival.

India

According to recent reports published by Business Standard, Deccan Herald, and India.com, there is a considerable likelihood that India will bypass purchasing the COVID-19 vaccine from Pfizer-BioNTech. Senior government officials in India have stated that the price tag that is attached to the Pfizer-BioNTech COVID-19 vaccine is far too steep for the country.
The vaccine from Pfizer costs around $37 per dose, and India is the world’s second-most populated country. The government of India would likely need to purchase at least 680 million doses, which would cost them an estimated $22.8 billion.
One senior government official stated, “There has been a lot of deliberation on whether the Pfizer shots would be accommodative for Indian population, given its high pricing and the public health infrastructure. ” The individual goes on to state that the Pfizer vaccine is not favorable for India’s national program due to the sub-zero storage requirement and cost.
The government is reportedly considering alternative options, such as Oxford-AstraZenaca’s Covidshield ($3 per dose), Russia’s Sputnik V ($10 per dose), or indigenous vaccines from Zydus Cadila and Bharat Biotech ($3-$6 per dose).
However, a report published by Business Standard on December 16, 2020, stated that India may be supplied with cheaper Pfizer COVID-19 vaccines, though a final offer has not been presented to the government.

Latin America

The Mexican government is set to commence a vaccination drive using the Pfizer-BioNTech COVID-19 vaccine by the end of December 2020. For this specific drive, approximately 250,000 doses of the Pfizer-BioNTech COVID-19 vaccine were ordered by the Mexican government to immunize 125,000 of its citizens (vaccine requires two separate shots). In total, the government has bought 34.4 million doses of this vaccine, with the intention of vaccinating one million people per month from January to March 2021 and about 12 million in April 2021.
On December 16, 2020, Chilean health officials approved the COVID-19 vaccine from Pfizer for use. These health officials also plan to commence the vaccination process before the conclusion of 2020, with hopes of vaccinating around one million citizens by march 2021. The country ordered approximately 10 million doses from Pfizer to vaccinate 5 million individuals.
As reported by Morning Star, Peru ordered around 9 million doses of the Pfizer vaccine, but the country does not anticipate to begin a vaccination drive “until the second quarter of 2021.”
In November 2020, Alberto Fernandez, the President of Argentina, stated that the nation may receive up to 750,000 doses of the Pfizer COVID-19 vaccine at some point in December 2020. However, the government also has plans to receive 60 million doses of different vaccines, including Sputnik V developed by Russia, during the first six months of 2021.

China

According to a report published by Bloomberg, the Shanghai Fosun Pharmaceutical Group Co. ordered 100 million doses of the Pfizer-BioNTech vaccine. It is expected that this order, at least the first 50 million doses, will begin arriving in China by 2021. The full 100 million doses is not expected to be completely supplied to the country until the end of 2021.

U.S.

On Friday, 11th of December 2020, the Food and Drug Administration (FDA) authorized the emergency use of Pfizer’s COVID-19 vaccine.
According to the FDA, “the known and potential benefits of Pfizer-BioNTech COVID‑19 vaccine outweigh its potential risks for people ages 16 and older.”
“Gen. Gustave Perna, chief operating officer of Operation Warp Speed,” projects, that the first vaccinations in US hospitals would begin on Monday, the 14th December 2020.
According to Gen. Gustave Perna, boxes of Pfizer’s COVID-19 vaccine will be delivered through UPS and FedEx hubs, “to 636 predetermined locations nationwide.” 145 locations are expected to the Pfizer COVID‑19 on the 14th of December, while the others will receive the vaccine on the 15th, and 16th December.
“An estimated 2.9 million doses will be distributed within the first week. That number is expected to ramp up significantly in the coming weeks, to as much as 40 million doses by the end of 2020.”

Canada

On Wednesday, 9th December 2020, Health Canada approved the use of Pfizer’s COVID-19 vaccine.
The first vaccinations are expected to begin in the 3rd week of December, and it is estimated that “every Canadian will be able to be inoculated” by the end of September 2021.
“About 249,000 doses of the two-dose vaccine are expected to arrive by Dec. 31 and the first inoculations will be to residents and staff in long-term nursing homes.”
Health Canada’s approval came after its “two months of review of the Pfizer clinical trials.”
According to Health Canada, “the date provided supports favorably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety.”

U.K.

91-year-old Margaret Keenan was the first recipient of the Pfizer COVID-19 vaccine, she was vaccinated at 06:31 GMT, Tuesday, 8th of December.
“The first 800,000 doses are going to people over 80 who are either hospitalized or already have outpatient appointments scheduled, along with nursing home workers.”
4 million vaccines are projected to be dispensed in the UK before the end of December 2020.
On 2nd December 2020, the British regulators gave emergency authorization to use the Pfizer COVID-19 vaccine.

EU

The European Medicines Agency (EMA) has received an application for conditional marketing authorization (CMA) for BNT162b2, a COVID‑19 mRNA vaccine developed by BioNTech and Pfizer.
“If EMA concludes that the benefits of the vaccine outweigh its risks in protecting against COVID‑19, it will recommend granting a conditional marketing authorization.”
EMA will meet on 29th December 2020 to conclude its assessment of the Pfizer COVID-19 vaccine. “If approved, the vaccine could begin to be distributed before year’s end.“
“European Commission President Ursula von der Leyen said Tuesday that the EU has secured around 2 billion doses of potential COVID-19 vaccine, according to The Associated Press. Deliveries to its 27 member nations will likely start before 2021.“

Japan

“Pfizer began conducting a small-scale trial in Japan on Oct. 20. Its results, as well as those of the large-scale global test, are expected to lead the U.S. drugmaker to file for approval in Japan.”
Starting early next year, Japan plans an orderly rollout of COVID-19 vaccines, that include thousands of freezers, “a reservation system and the repurposing of non-medical facilities as vaccination sites.”
According to Satoshi Hori, professor of infectious disease control at Juntendo University in Tokyo, vaccines are expected to become available in Japan between March and May. Also, Japan plans to vaccinate its people before it hosts the Summer Olympics on July 23, 2021.

China

“China, which is expected to approve mass production of locally developed vaccine candidates by the end of December, has pledged to share them with neighboring countries in a diplomatic charm offensive.”
During an October visit to Cambodia, China Foreign Minister Wang Yi, said that Beijing will provide Chinese vaccines to the Southeast Asian countries on a priority basis.